These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23694748)

  • 1. Acellular vaccines provided less protection during California pertussis outbreak.
    McCarthy M
    BMJ; 2013 May; 346():f3325. PubMed ID: 23694748
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control.
    Kirkland KB; Talbot EA; Decker MD; Edwards KM
    Clin Infect Dis; 2009 Aug; 49(4):584-7. PubMed ID: 19589084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.
    Wei SC; Tatti K; Cushing K; Rosen J; Brown K; Cassiday P; Clark T; Olans R; Pawloski L; Martin M; Tondella ML; Martin SW
    Clin Infect Dis; 2010 Aug; 51(3):315-21. PubMed ID: 20578875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arm your patients against whooping cough.
    Heavey E
    Nursing; 2008 Feb; 38(2):22-3. PubMed ID: 18223407
    [No Abstract]   [Full Text] [Related]  

  • 6. More than just a cough: pertussis, and the nurse's role in school and community health.
    Roper JD
    School Nurse News; 2006 Mar; 23(2):26-8. PubMed ID: 16634406
    [No Abstract]   [Full Text] [Related]  

  • 7. California pertussis epidemic, 2010.
    Winter K; Harriman K; Zipprich J; Schechter R; Talarico J; Watt J; Chavez G
    J Pediatr; 2012 Dec; 161(6):1091-6. PubMed ID: 22819634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetanus, diphtheria, and acellular pertussis vaccine: a position statement of the Society for Adolescent Medicine.
    Middleman AB; Bruner A
    J Adolesc Health; 2009 Sep; 45(3):316-7. PubMed ID: 19699431
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistent pertussis.
    Ortolon K
    Tex Med; 2002 Jun; 98(6):38-42. PubMed ID: 12073900
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F; Habermehl P; Knuf M; Mannhardt-Laakman W; Howe B; Friedland LR
    Vaccine; 2007 Jul; 25(29):5248-52. PubMed ID: 17583395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bordetella pertussis booster vaccination for health care personnel immediately following a pertussis outbreak in a hospital?
    Birkebaek NH
    Clin Infect Dis; 2009 Aug; 49(4):588-90. PubMed ID: 19589080
    [No Abstract]   [Full Text] [Related]  

  • 12. Pertussis--a disease and vaccine for all ages.
    Halperin SA
    N Engl J Med; 2005 Oct; 353(15):1615-7. PubMed ID: 16221785
    [No Abstract]   [Full Text] [Related]  

  • 13. Pertussis vaccines for adolescents and adults.
    Cherry JD
    Pediatrics; 2005 Sep; 116(3):755-6. PubMed ID: 16140719
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F; Knuf M; Habermehl P; Mannhardt-Laakmann W; Howe B; Friedland LR
    J Pediatr; 2006 Nov; 149(5):603-610. PubMed ID: 17095328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing pertussis in infants by vaccinating adults.
    Finger R; Shoemaker J
    Am Fam Physician; 2006 Aug; 74(3):382. PubMed ID: 16913156
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety evaluation of one whole-cell and three acellular pertussis vaccines in Stockholm trial II.
    Heijbel H; Rasmussen F; Olin P
    Dev Biol Stand; 1997; 89():99-100. PubMed ID: 9272337
    [No Abstract]   [Full Text] [Related]  

  • 18. Recommendation for an adolescent dose of tetanus and diphtheria toxoids and acellular pertussis vaccine: reassurance for the future.
    Halperin SA
    J Pediatr; 2006 Nov; 149(5):589-91. PubMed ID: 17095321
    [No Abstract]   [Full Text] [Related]  

  • 19. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak.
    Talbot EA; Brown KH; Kirkland KB; Baughman AL; Halperin SA; Broder KR
    Vaccine; 2010 Nov; 28(50):8001-7. PubMed ID: 20875487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming with whole-cell versus acellular pertussis vaccine.
    Liko J; Robison SG; Cieslak PR
    N Engl J Med; 2013 Feb; 368(6):581-2. PubMed ID: 23388023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.